Thomas Dayspring/LinkedIn
Jul 27, 2026, 16:57
Thomas Dayspring։ Could PCSK9 Inhibitors Reduce the Risk of Retinal Vascular Occlusions?
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared a post on LinkedIn about a recent article by Isabella H. Yazji et al, published in American Journal of Ophthalmology, adding:
”Of interest – The Impact of PCSK9 Inhibitors on Development of Retinal Vascular Occlusions.”
Title: The Impact of PCSK9 Inhibitors on Development of Retinal Vascular Occlusions
Authors: Isabella H. Yazji, Nadia J. Abbass, David C. Kaelber, Katherine E. Talcott, Rishi P. Singh
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 14, 2026, 23:23Farjah Algahtani: Stroke Incidence and Risk Factors in Saudi Patients with Sickle Cell Disease
-
Sep 14, 2026, 20:53YoonHwa An: Rusfertide in Polycythemia Vera – From Clinical Benefit to Strategic Value
-
Sep 14, 2026, 20:52Andres Alberto Mercado Pompa: External Validation of Prognostic Risk Scores in Cerebral Venous Thrombosis
-
Sep 14, 2026, 20:50Balaji Kirushnan: Advancing Regional Citrate Anticoagulation in CRRT – From Experience to Implementation
-
Sep 14, 2026, 20:48Valerie Dehondt: Nutritional Anemia Is Associated With Increased Risk of Severe COPD Exacerbations
-
Sep 14, 2026, 20:46Nupur Choudhury: Exploring AI-Based Detection of Anemia Using Eye and Fingernail Images
-
Sep 14, 2026, 20:44Shamee Shastry: Chart Before You Chase – Diagnosing Drug-Induced Hemolytic Anemia
-
Sep 14, 2026, 20:43David Reiner: Blood Tests That Can Reveal Nutrition Clues
-
Sep 14, 2026, 20:40Giuseppe Biondi Zoccai: Balancing Thrombosis and Bleeding in Acute MI With Hemophilia A